| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $841,739 ) |
| 2024 | 2024 | DAYTON CLINICAL ONCOLOGY PROGRAM, INC. | 6480 CENTERVILLE BUSINESS PKWY | DAYTON | OH | 45459 | MONTGOMERY | USA | Cancer Control | 000 | 11 | 7/23/2024 | NON-COMPETING CONTINUATION | $841,739 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $896,265 ) |
| 2023 | 2023 | DAYTON CLINICAL ONCOLOGY PROGRAM, INC | 6480 CENTERVILLE BUSINESS PKWY | DAYTON | OH | 45459 | MONTGOMERY | USA | Cancer Control | 000 | 10 | 7/24/2023 | NON-COMPETING CONTINUATION | $896,265 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $998,150 ) |
| 2022 | 2022 | DAYTON CLINICAL ONCOLOGY PROGRAM, INC | 6480 CENTERVILLE BUSINESS PKWY | DAYTON | OH | 45459 | MONTGOMERY | USA | Cancer Control | 000 | 9 | 7/28/2022 | NON-COMPETING CONTINUATION | $998,150 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $950,647 ) |
| 2021 | 2021 | DAYTON CLINICAL ONCOLOGY PROGRAM, INC | 6480 CENTERVILLE BUSINESS PKWY | DAYTON | OH | 45459 | MONTGOMERY | USA | Cancer Control | 000 | 8 | 7/27/2021 | NON-COMPETING CONTINUATION | $950,647 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $930,647 ) |
| 2020 | 2020 | DAYTON CLINICAL ONCOLOGY PROGRAM, INC | 6480 CENTERVILLE BUSINESS PKWY | DAYTON | OH | 45459 | MONTGOMERY | USA | Cancer Control | 001 | 7 | 7/28/2020 | NON-COMPETING CONTINUATION | $930,647 |
| 2020 | 2018 | DAYTON CLINICAL ONCOLOGY PROGRAM, INC | 6480 CENTERVILLE BUSINESS PKWY | DAYTON | OH | 45459 | MONTGOMERY | USA | Cancer Treatment Research | 000 | 5 | 3/16/2020 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $930,647 ) |
| 2019 | 2019 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3123 RESEARCH BLVD # 150 | DAYTON | OH | 45420 | MONTGOMERY | USA | Cancer Control | 000 | 6 | 8/15/2019 | COMPETING CONTINUATION | $930,647 |
| 2019 | 2019 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3123 RESEARCH BLVD # 150 | DAYTON | OH | 45420 | MONTGOMERY | USA | Cancer Control | 001 | 6 | 8/16/2019 | COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2018 ( Subtotal = $783,697 ) |
| 2018 | 2018 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3123 RESEARCH BLVD # 150 | DAYTON | OH | 45420 | MONTGOMERY | USA | Cancer Treatment Research | 000 | 5 | 7/27/2018 | NON-COMPETING CONTINUATION | $783,697 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2017 ( Subtotal = $936,120 ) |
| 2017 | 2017 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3123 RESEARCH BLVD # 150 | DAYTON | OH | 45420 | MONTGOMERY | USA | Cancer Treatment Research | 000 | 4 | 8/1/2017 | NON-COMPETING CONTINUATION | $930,000 |
| 2017 | 2017 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3123 RESEARCH BLVD # 150 | DAYTON | OH | 45420 | MONTGOMERY | USA | Cancer Treatment Research | 001 | 4 | 8/14/2017 | NON-COMPETING CONTINUATION | $6,120 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2016 ( Subtotal = $855,000 ) |
| 2016 | 2016 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3525 SOUTHERN BOULEVARD | DAYTON | OH | 45429 | MONTGOMERY | USA | Cancer Treatment Research | 000 | 3 | 7/25/2016 | NON-COMPETING CONTINUATION | $855,000 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2015 ( Subtotal = $855,000 ) |
| 2015 | 2015 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3525 SOUTHERN BOULEVARD | DAYTON | OH | 45429 | MONTGOMERY | USA | Cancer Treatment Research | 000 | 2 | 7/29/2015 | NON-COMPETING CONTINUATION | $855,000 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2014 ( Subtotal = $1,005,000 ) |
| 2014 | 2014 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3525 SOUTHERN BOULEVARD | DAYTON | OH | 45429 | MONTGOMERY | USA | Cancer Treatment Research | 000 | 1 | 7/31/2014 | NEW | $855,000 |
| 2014 | 2014 | DAYTON CLINICAL ONCOLOGY PROGRAM | 3525 SOUTHERN BOULEVARD | DAYTON | OH | 45429 | MONTGOMERY | USA | Cancer Treatment Research | 001 | 1 | 9/19/2014 | NEW | $150,000 |
|
|